Outcome of neuropsychiatric symptoms and daily functioning of patients with dementia treated on an acute psychogeriatric ward

References

• Mangialasche F, Kivipelto M, Solomon A, et al. Dementia prevention: current epidemiological evidence and future perspective. Alzheimers Res Ther. 2012;4:6.
   PubMed Web of Science ®Google Scholar
• Winblad B, Amouyel P, Andrieu S. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15:455–532.
   PubMed Web of Science ®Google Scholar
• Schaller S, Mauskopf J, Kriza C, et al. The main cost drivers in dementia: a systematic review. Int J Geriatr Psychiatry. 2015;30:111–129.
   PubMed Web of Science ®Google Scholar
• Steinberg M, Shao H, Zandi P, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriat Psychiatry. 2008;23:170–177.
   PubMed Web of Science ®Google Scholar
• Borsje P, Wetzels RB, Lucassen PL, et al. The course of neuropsychiatric symptoms in community-dwelling patients with dementia: a systematic review. Int Psychogeriatr. 2015;27:385–405.
   PubMed Web of Science ®Google Scholar
• Svendsboe E, Terum T, Testad I, et al. Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2016;31:1075–1083.
   PubMed Web of Science ®Google Scholar
• Brodaty H, Connors MH, Xu J, PRIME study group, et al. Predictors of institutionalization in dementia: a three year longitudinal study. J Alzheimers Dis. 2014;40:221–226.
   PubMed Web of Science ®Google Scholar
• Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73.
   PubMedGoogle Scholar
• Gauthier S, Cummings J, Ballard C, et al. Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr. 2010;22:346–372.
   PubMed Web of Science ®Google Scholar
• Alanen H-M, Pitkänen A, Suontaka-Jamalainen K, et al. Acute psychogeriatric inpatient treatment improves neuropsychiatric symptoms but impairs the level of functioning in patients with dementia. Dement Geriatr Cogn Disord. 2015;40:290.
   PubMed Web of Science ®Google Scholar
• Kuronen M, Kautiainen H, Karppi P, et al. Antipsychotic drug use and associations with neuropsychiatric symptoms in persons with impaired cognition: a cross-sectional study. Nord J Psychiatry. 2016;70:621–625.
   PubMed Web of Science ®Google Scholar
• Maust DT, Langa KM, Blow FC, et al. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA. Int J Geriatr Psychiatry. 2017;32:164–174.
   PubMed Web of Science ®Google Scholar
• Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934–1943.
   PubMed Web of Science ®Google Scholar
• Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952–1960.
   PubMedGoogle Scholar
• Ihl R, Bunevicius R, Frölich L, et al. World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care. Int J Psychiatry Clin Pract. 2015;19:2–7.
   PubMed Web of Science ®Google Scholar
• Reus VI, Fochtmann LJ, Eyler AE, et al. The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am J Psychiatry. 2016;173:543–546.
   PubMed Web of Science ®Google Scholar
• Finnish Medical Society Duodecim. Current care guidelines: memory disorders. (in Finnish with English summary); [cited 2018 Jan 3]. Available from: http://www.kaypahoito.fi/web/kh/suositukset/suositus?id=hoi50044.
   Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194.
   PubMed Web of Science ®Google Scholar
• Folstein M, Folstein S, McHug P. “Minimental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
   PubMed Web of Science ®Google Scholar
• Cummings J, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314.
   PubMed Web of Science ®Google Scholar
• Galasko D, Bennett S, Sano M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. The Alzheimer’s disease cooperative study. Alzheimer Dis Assoc Disord. 1997;11: 33–39.
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Pressler M, Nopoulos P, et al. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry. 2010;67:255–262.
   PubMed Web of Science ®Google Scholar
• Lai CK, Yeung JH, Mok V, et al. Special care units for dementia individuals with behavioural problems. Cochrane Database Syst Rev. 2009;4:CD006470.
   Google Scholar
• Andersen CK, Wittrup-Jensen KU, Lolk A, et al. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes. 2004;2:52.
   PubMedGoogle Scholar
• Gustavsson A, Brinck P, Bergvall N, et al. Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients. Alzheimers Dement. 2011;7:318–327.
   PubMed Web of Science ®Google Scholar
• Reed C, Belger M, Vellas B, et al. Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer’s disease. Int Psychogeriatr. 2016;28:247–259.
   PubMed Web of Science ®Google Scholar
• Defrancesco M, Marksteiner J, Fleischhacker WW, et al. Use of benzodiazepines in Alzheimer’s disease: A systematic review of literature. Int J Neuropsychopharmacol. 2015;18:pyv055.
   PubMed Web of Science ®Google Scholar
• Taipale H, Koponen M, Tanskanen A, et al. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer’s disease. Int Clin Psychopharmacol. 2015;30:202–208.
   PubMed Web of Science ®Google Scholar
• Chodos AH, Kushel MB, Greysen SR, et al. Hospitalization-associated disability in adults admitted to a safety-net hospital. J Gen Intern Med. 2015;30:1765–1772.
   PubMed Web of Science ®Google Scholar
• Covinsky KE, Pierluissi E, Johnston CB. Hospitalization-associated disability:She was probably able to ambulate, but I'm not sure. JAMA. 2011;306:1782–1793.
   PubMed Web of Science ®Google Scholar
• Cepoiu-Martin M, Tam-Tham H, Patten S, et al. Predictors of long-term care placement in persons with dementia: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2016;31:1151–1171.
   PubMed Web of Science ®Google Scholar
• Koponen M, Tolppanen A-M, Taipale H, et al. Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons. Br J Psychiatry. 2015;207:444–449.
   PubMed Web of Science ®Google Scholar
• de Souto Barreto P, Demougeot L, Pillard F, et al. Exercise training for managing behavioral and psychological symptoms in people with dementia: a systematic review and meta-analysis. Aging Res Rev. 2015;24:274–285.
   PubMed Web of Science ®Google Scholar
• de Oliveira AM, Radanovic M, de Mello PC, et al. Nonpharmacological interventions to reduce behavioral and psychological symptoms of dementia: a systematic review. Biomed Res Int. 2015;2015:1.
   Web of Science ®Google Scholar